ArticleEuropean journal of applied physiology2026
The causal effects of immune factors on sarcopenia-related phenotypes.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
While immune dysregulation is implicated in sarcopenia, the causal roles of specific innate immune cell subsets and their functional states remain unclear. We conducted a two-sample Mendelian randomization (MR) analysis to assess the causal effects of 731 immune traits on core sarcopenia phenotypes. After false discovery rate correction, 14 robust associations were identified, revealing a state-dependent duality within myeloid cells. Specifically, a higher absolute count of pro-inflammatory CD14-CD16+ monocytes was linked to reduced right hand grip strength (RHGS), whereas a higher count of intermediate CD14+ CD16+ monocytes and increased CD16 expression on this subset were associated with improved strength. Conversely, the relative abundance of classical CD14+CD16- monocytes was positively associated with appendicular lean mass (ALM). Similarly, the relative abundance of total myeloid dendritic cells (DCs) correlated positively with lean mass, while a higher absolute count of activated CD62L-CD86+ DCs was linked to poorer strength. Reverse analysis largely supported the primary causal direction. These findings provide genetic evidence that specific innate immune subsets influence sarcopenia in a manner critically dependent on cellular identity and functional state, refining the mechanistic link between immunosenescence and muscle decline.
Indexed as
Identifiers
42550241What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.